Cargando…
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
Malignant pleural mesothelioma (MPM) is an aggressive tumor linked to environmental/occupational exposure to asbestos, characterized by the presence of significant areas of hypoxia. In this study, we firstly explored the expression and the role of transglutaminase 2 (TG2) in MPM cell adaptation to h...
Autores principales: | Zonca, Sara, Pinton, Giulia, Wang, Zhuo, Soluri, Maria Felicia, Tavian, Daniela, Griffin, Martin, Sblattero, Daniele, Moro, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386478/ https://www.ncbi.nlm.nih.gov/pubmed/28151477 http://dx.doi.org/10.1038/cddis.2017.30 |
Ejemplares similares
-
Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017) -
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells
por: Pinton, Giulia, et al.
Publicado: (2016) -
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
por: Manente, Arcangela G., et al.
Publicado: (2015) -
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
por: Al Khatib, MHD Ouis, et al.
Publicado: (2023) -
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition
por: Ayinde, Oluseyi, et al.
Publicado: (2019)